• Biomimetic Chromatography for Pulmonary Permeability

  2026-09-10

  This study provides a direct comparison of immobilised artificial membrane liquid chromatography and liposome electrokinetic capillary chromatography for modelling drug–membrane partitioning and pulmonary permeability. Its findings position LEKC as the more physiologically informative approach for many compounds, while IAM LC remains attractive for broad, robust, and high-throughput screening.

• STING, CD40, and TLS in ESCC B-Cell Activation

  2026-09-09

  A recent ESCC study links tertiary lymphoid structures with favorable survival and identifies IRF4-positive B-cell activation as a central immune feature. Its mechanistic contribution is the demonstration that CD40 and STING compete for TRAF2, connecting non-canonical NF-κB signaling with TLS-associated antitumor immunity.

• REV1–DHX36 Control of G-Quadruplex Replication

  2026-09-09

  A 2026 Nucleic Acids Research study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. The work defines a two-tier mechanism for G4 tolerance and clarifies how REV1 deficiency alters mutagenesis, replication dynamics, and ATM/ATR DNA damage signaling.

• Moxifloxacin Research Workflows and Applications

  2026-09-08

  Moxifloxacin supports complementary bacterial gyrase, mammalian cytotoxicity, and preclinical metabolic-response studies. This guide translates its chemical properties and dose-dependent biology into practical assay workflows, controls, and troubleshooting decisions.

• Functional Metagenomics Reveals Cas9 Inhibitors

  2026-09-08

  Forsberg et al. developed a functional metagenomic selection that identifies anti-CRISPR proteins by linking Cas9 inhibition to bacterial survival. The approach recovered potent inhibitors from human oral and fecal microbiomes, including AcrIIA11, which functions in bacteria and human cells through a mechanism distinct from previously characterized Type II-A anti-CRISPRs.

• HD56 Prodrug PK and Humanized Mouse Evidence

  2026-09-07

  The 2025 HD56 study shows how ester prodrug metabolism can vary substantially across species and identifies humanized-liver mice as the only tested model with a strong in vivo–in vitro correlation. Its integrated transport, enzyme-phenotyping, microsomal, plasma, and pharmacokinetic design provides a practical framework for improving translational assessment of carboxylate ester prodrugs.

• Carbapenemase Gene Transmission in CREC

  2026-09-07

  This study combines gene localization, conjugation testing, mobile-element analysis, strain typing, and clinical epidemiology to clarify how carbapenemase-encoding genes spread among carbapenem-resistant Enterobacter cloacae in eight Guangdong teaching hospitals. Its findings identify plasmid-associated blaNDM-1, extensive multidrug resistance, and strong transfer potential as priorities for surveillance and mechanistic resistance research.

• Cyclic Pifithrin-α Hydrobromide in p53 Assays

  2026-09-05

  Cyclic Pifithrin-α hydrobromide is a practical p53 inhibitor for dissecting stress responses, apoptosis, and DNA damage signaling. This article explains how to position it within mechanistic neuroinflammation assays without overstating evidence from trigeminal pain research.

• Aminopeptidase Selectivity of ACE Inhibitors

  2026-09-04

  Tieku and Hooper directly compared bestatin, aminopeptidase inhibitors, and several ACE inhibitor classes against porcine kidney aminopeptidases A, N, and W. Their results show that inhibitor selectivity is highly structure- and enzyme-dependent, providing an important basis for interpreting off-target effects in peptidase and cardiovascular research.

• NUAK1/2 Inhibition Lowers Tau Ser356 in AD Models

  2026-09-04

  Taylor et al. identify tau phosphorylation at Ser356 as a pathology-associated feature of Alzheimer’s disease and test its pharmacological regulation with the NUAK1/2 inhibitor WZ4003. The study combines post-mortem human tissue, array tomography, and ex vivo mouse and human brain-slice cultures, revealing disease-associated p-tau Ser356 and distinct species-dependent responses to NUAK inhibition.

• HRP Goat Anti-Mouse IgG (H+L) Antibody

  2026-09-03

  HRP Goat Anti-Mouse IgG (H+L) Antibody (SKU K1221) provides enzyme-based detection of mouse primary antibodies in Western blot, ELISA, IHC, and ICC workflows. It should be used with HRP-compatible substrates and validated for the specific mouse primary antibody, but not assumed suitable for fluorescence-only assays or non-mouse primary antibodies.

• Okadaic acid A4540: PP1/PP2A Workflow

  2026-09-03

  Okadaic acid (A4540) provides controlled inhibition of PP2A at low nanomolar activity and engages PP1 more strongly at higher concentrations, supporting phosphorylation-dependent signaling and apoptosis assay design. It is appropriate for validated PP1/PP2A biochemical and cell workflows, but should not be treated as a PP1-only probe or used without solvent-matched controls and application-specific titration.

• Matriptase Exosomes and the Second EGF Signal

  2026-09-02

  The reference study identifies endosomal activation and exosomal release of matriptase as a mechanism that converts an initial EGF–EGFR response into a second, HGF/c-Met-dependent signal promoting skin and breast cancer invasion. Its trafficking-centered model links receptor internalization, acidic protease activation, pro-HGF processing, and tumor-cell motility, providing a framework for studying reciprocal regulation between growth-factor signaling and membrane proteases.

• Bazedoxifene: ER and IL-6/GP130 Research Workflows

  2026-09-02

  Bazedoxifene enables complementary studies of estrogen receptor biology, bone mineral density enhancement, and emerging IL-6/GP130 pathway inhibition. This workflow-focused guide shows how to control solubility, separate receptor signaling from cytotoxicity, and build orthogonal assays for osteoporosis treatment research and cancer-focused repurposing studies.

• FXR Phase Separation Clusters Viral Organelles

  2026-09-01

  The reference study identifies fragile X–related proteins as host factors that organize coronavirus double-membrane vesicles through liquid–liquid phase separation. Its findings connect condensate biology with replication-organelle architecture and suggest experimental strategies for separating organelle clustering, viral RNA synthesis, and translation in mechanistic antiviral studies.

8576 records 1/572 page Next 12345 下5页 Last page